Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer
2020 · Journal of Cancer · 44 citations
https://doi.org/10.7150/jca.49567
X
Xuanrong Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
589
Citations
13
h-index
16
i10-index
Xuanrong Chen is an academic researcher from Changzhi University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Ubiquitin and proteasome pathways & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 13, co-authored 34 publications.
ORCID: 0000-0003-4694-4579Papers by this author
worksSuper-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
2020 · npj Precision Oncology · 34 citations
https://doi.org/10.1038/s41698-020-00137-0
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer
2023 · Cell Death and Disease · 12 citations
https://doi.org/10.1038/s41419-023-05742-y
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
2022 · Cell Death and Disease · 8 citations
https://doi.org/10.1038/s41419-022-05366-8
Glucokinase activator improves glucose tolerance and induces hepatic lipid accumulation in mice with diet-induced obesity
2023 · Liver Research · 5 citations
https://doi.org/10.1016/j.livres.2023.05.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat